FC
INSP icon

Farringdon Capital’s Inspire Medical Systems INSP Stock Holding History

Farringdon Capital’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,543
Closed -$286K – 470
2024
Q4 		$286K Buy
+1,543
New +$300K 0.12% 294

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Farringdon Capital's INSP Position: Q1 2025 in Review

Farringdon Capital sold out of Inspire Medical Systems (INSP) in Q1 2025, closing a stake of 1,543 shares — an estimated $286K sold.

Farringdon Capital first reported a position in INSP in Q4 2024 and held it in 1 quarter. The position peaked at $286K in Q4 2024. 363 funds tracked by Wall St. Rank hold INSP as of Q1 2025.

  • Farringdon Capital reported no remaining Inspire Medical Systems position as of Q1 2025 after selling out during the quarter.
  • Farringdon Capital sold 1,543 Inspire Medical Systems shares in Q1 2025, an estimated $286K.
  • Farringdon Capital first reported a position in Inspire Medical Systems in Q4 2024 and held it in 1 quarter.
  • Farringdon Capital's Inspire Medical Systems position peaked at $286K in Q4 2024.
  • 363 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2025.

Based on Farringdon Capital's 13F filing for Q1 2025, filed 15 May 2025.